influenza vlp vaccine
Vaccineexperimental
Clinical trial activity
25 trials · 30 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
18
Phase 3
4
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00754455)
Timeline
Indications
Studied for
- Head and Neck Neoplasms · Phase 1/Phase 2
- Influenza A virus · Phase 1
- Influenza A Virus, H5N1 Subtype · Phase 1
- Influenza A Virus, H5N2 Subtype · Phase 2
- Influenza, Human · Phase 3
- Influenza in Birds · Phase 1
- Papillomaviridae · Phase 1/Phase 2
- Respiratory Tract Diseases · Phase 3
- Respiratory Tract Infections · Phase 3
- RNA Virus Infections · Phase 3
- Virus Diseases · Phase 3
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adjuvanted quadrivalent influenza vlp vaccine
- avian flu vaccine
- h5 vlp
- h5-vlp
- h5 vlp vaccine
- h7 vlp vaccine
- influenza vlp vaccine
- monovalent h5n1 avian influenza vlp vaccine
- monovalent h7n9 avian influenza vlp vaccine
- quadrivalent influenza vlp vaccine
- quadrivalent virus-like particles influenza vaccine
- quadrivalent vlp influenza vaccine
- quadrivalent vlp vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03739112 | Phase 3 | Sep 18, 2018 | Medicago |
| NCT03321968 | Phase 3 | Sep 29, 2017 | Medicago |
| NCT03301051 | Phase 3 | Aug 31, 2017 | Medicago |
| NCT03162224 | Phase 1/Phase 2 (Phase 2) | May 26, 2017 | MedImmune |
| NCT02831751 | Phase 2 | Apr 1, 2016 | Broward Research Group, Centre de Recherche St-Louis, Quebec, Canada, INC Research, McGill University, Medicago, Meridien Research, MRA Clinical Research, Omnispec Clinical Research Inc, Mirabel, Canada, Paradigm Research, Regional Clinical Research, Topstone Research, Toronto, Canada, University of Montreal |
| NCT02768805 | Phase 2 | Mar 1, 2016 | Broward Research Group, Centre de Recherche St-Louis, Quebec, Canada, McGill University, Medicago, MRA Clinical Research, Regional Clinical Research, Topstone Research, Toronto, Canada, University of Montreal |
| NCT02307851 | Phase 2 | Nov 1, 2014 | Department of Health and Human Services, Novavax |
| NCT02255409 | Phase 3 | Oct 1, 2014 | CSL Behring |
| NCT02236052 | Phase 2 | Aug 1, 2014 | inVentiv, McGill University, Medicago |
| NCT02233816 | Phase 2 | Aug 1, 2014 | Broward Research Group, Medicago, MRA Clinical Research |
| NCT02078674 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2014 | Department of Health and Human Services, Novavax |
| NCT02022163 | Phase 1 | Dec 1, 2013 | Canadian Science Centre for Human and Animal Health, Government of Canada, Health Sciences Centre Foundation, Manitoba, INC Research, Medicago |
| NCT01991587 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2013 | Medicago, MRA Clinical Research |
| NCT01897701 | Phase 1 | Jul 1, 2013 | Novavax |
| NCT01991561 | Phase 2 | Jun 1, 2013 | INC Research, McGill University, Medicago |
| NCT01841918 | Phase 2 | Jan 1, 2013 | Mahidol University, The Government Pharmaceutical Organization, World Health Organization |
| NCT01657929 | Phase 1 | Sep 1, 2012 | Defense Advanced Research Projects Agency, Immune Design, Infectious Disease Research Institute, Medicago |
| NCT01596725 | Phase 1 | May 1, 2012 | Department of Health and Human Services, Novavax |
| NCT01656356 | Phase 1 | May 1, 2012 | Mahidol University |
| NCT01594320 | Phase 1 | Apr 1, 2012 | Department of Health and Human Services, Novavax |
Showing 20 of 25 trials
Page 1 / 2
Organizations
Research & Development (30)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medicago | For profit | 13 | 12 | 3 | 2009 |
| Novavax | For profit | 8 | 8 | 2 | 2008 |
| McGill University | Academic/Hospital | 5 | 0 | 2 | 2009 |
| Department of Health and Human Services | Government | 4 | 0 | 2 | 2012 |
| INC Research | For profit | 4 | 0 | 2 | 2010 |
| MRA Clinical Research | Academic/Hospital | 4 | 0 | 1 | 2013 |
| Broward Research Group | Academic/Hospital | 3 | 0 | 1 | 2014 |
| Centre de Recherche St-Louis, Quebec, Canada | Academic/Hospital | 2 | 0 | 1 | 2016 |
| Mahidol University | Academic/Hospital | 2 | 2 | 2 | 2012 |
| Regional Clinical Research | For profit | 2 | 0 | 1 | 2016 |
| Topstone Research, Toronto, Canada | For profit | 2 | 0 | 1 | 2016 |
| University of Montreal | Academic/Hospital | 2 | 0 | 1 | 2016 |
| Benchmark Research | For profit | 1 | 0 | 1 | 2008 |
| Canadian Science Centre for Human and Animal Health | Academic/Hospital | 1 | 0 | 1 | 2013 |
| CSL Behring | For profit | 1 | 1 | 1 | 2014 |
| Defense Advanced Research Projects Agency | Government | 1 | 0 | 1 | 2012 |
| Government of Canada | Government | 1 | 0 | 1 | 2013 |
| Health Sciences Centre Foundation, Manitoba | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Immune Design | For profit | 1 | 0 | 1 | 2012 |
| Infectious Disease Research Institute | Academic/Hospital | 1 | 1 | 1 | 2012 |
30 organizations
Page 1 / 2